Trials / Completed
CompletedNCT06174961
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin: A Randomized, Controlled, Cross-over Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Kristian Karstoft · Academic / Other
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The aim of this project is to assess the influence of exercise on pharmacokinetics (PK) and pharmacodynamics (PD) of a single dose of subcutaneously (sc) administered unfractionated heparin (UFH). It is hypothesized that exercise will increase the systemic exposure (PK) and therefore the clinical effects (PD) of the sc administered UFH. To assess this, healthy male volunteers will be included in a controlled, randomized, crossover study, where they, on four separate days, will have UFH injected sc in the thigh, followed by different exercise interventions (one per experimental day). Blood sampling, with the aim of assessing PK and PD will be performed during the following hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Unfractionated heparin | 15,000 units of unfractionated heparin administered in the thigh |
| BEHAVIORAL | Double-legged cycle ergometer exercise | One hour of double-leg cycle ergometer exercise |
| BEHAVIORAL | Single-legged cycle ergometer exercise, with unfractionated heparin injection in the exercising leg | One hour of single-leg cycle ergometer exercise, after unfractionated heparin injection in the ipsilateral leg |
| BEHAVIORAL | Single-legged cycle ergometer exercise, with unfractionated heparin injection in the non-exercising leg | One hour of single-leg cycle ergometer exercise, after unfractionated heparin injection in the ipsilateral leg |
| BEHAVIORAL | No exercise | No exercise |
Timeline
- Start date
- 2023-09-22
- Primary completion
- 2024-02-13
- Completion
- 2024-05-01
- First posted
- 2023-12-18
- Last updated
- 2024-06-26
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06174961. Inclusion in this directory is not an endorsement.